Company Directory / medical practice

PrivateFor profitmedical practicePalo Alto, United States
Delfi Diagnostics detects cancer early, when it is most curable, using high precision non-invasive blood tests.
Size
101-250 people: larger than 85% of companies with a size listed
Age
7 years old.
Reach
Website ranked #5,341,746 in the world for traffic, about 1k visits a month.
Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsMedical
Funding, as listed
$331M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Delfi Diagnostics, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Delfi Diagnostics may be growing as evidenced by its recent collaboration with City of Hope to improve lung cancer screening rates in underserved areas, indicating an expansion of its operational reach and potential impact on public health. Additionally, the company has launched a new cancer-monitoring blood test, which suggests product development and innovation. Furthermore, the appointment of a new Chief Executive Officer could signal a strategic move to strengthen leadership and drive further growth.
Summaries written by the source dataset, not by us, and not checked.
medical practice in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.